Medigene  - logo

Medigene - Company & Market Research Reports

Medigene is a biotechnology company founded in 1994 and is headquartered in Munich, Germany. The company focuses on creating treatment platforms to fight against different forms of cancer. They produce treatment platforms using the T cell, these 3 platforms are: TCR’s, DC’s & TABS. They have a partnership with bluebird bio, Inc. for the development of T cell receptors. They also create products for genital warts, solid tumours and autoimmune diseases.


Competitor Analysis: Human Papilloma Virus (HPV) Vaccines & Therapeutics - Product Thumbnail Image

Competitor Analysis: Human Papilloma Virus (HPV) Vaccines & Therapeutics

  • Report
  • 43 Pages
From
Genital Warts (Condylomata Acuminata) - Pipeline Review, H2 2015 - Product Thumbnail Image

Genital Warts (Condylomata Acuminata) - Pipeline Review, H2 2015

  • Report
  • 77 Pages
From
Intracellular Targets Made Druggable by TCR-like Antibodies, TCR Fusion Proteins & Cell-Penetrating Biologics 2018: An Industry Analysis of Technologies, Stakeholders, Deals & Trends - Product Thumbnail Image

Intracellular Targets Made Druggable by TCR-like Antibodies, TCR Fusion Proteins & Cell-Penetrating Biologics 2018: An Industry Analysis of Technologies, Stakeholders, Deals & Trends

  • Report
  • 252 Pages
From
Global Dendritic Cell Cancer Vaccine Market & Clinical Trials Outlook 2023 - Product Thumbnail Image

Global Dendritic Cell Cancer Vaccine Market & Clinical Trials Outlook 2023

  • Report
  • 170 Pages
From
Global Dendritic Cell Cancer Vaccine Market Dosage Price & Clinical Trials Outlook 2024 - Product Thumbnail Image

Global Dendritic Cell Cancer Vaccine Market Dosage Price & Clinical Trials Outlook 2024

  • Report
  • 255 Pages
From
Competitor Analysis: Cancer Vaccines - Product Thumbnail Image

Competitor Analysis: Cancer Vaccines

  • Report
  • 179 Pages
From
Human Papillomavirus Infections - Pipeline Review, H2 2015 - Product Thumbnail Image

Human Papillomavirus Infections - Pipeline Review, H2 2015

  • Report
  • 164 Pages
From
Human Papillomavirus Infections - Pipeline Review, H1 2015 - Product Thumbnail Image

Human Papillomavirus Infections - Pipeline Review, H1 2015

  • Report
  • 144 Pages
From
Rheumatoid Arthritis - Pipeline Review, H1 2017 - Product Thumbnail Image

Rheumatoid Arthritis - Pipeline Review, H1 2017

  • Report
  • 1020 Pages
From
Dendritic Cell and Tumor Cell Cancer Vaccines Market, 2016-2030 - Product Thumbnail Image

Dendritic Cell and Tumor Cell Cancer Vaccines Market, 2016-2030

  • Report
  • 314 Pages
From
Report package: T-Cell Immunotherapy by Bispecific Antibodies and CAR & TCR Engineered T-cells - Product Thumbnail Image

Report package: T-Cell Immunotherapy by Bispecific Antibodies and CAR & TCR Engineered T-cells

  • Report
  • 618 Pages
From
Renal Cell Carcinoma - Pipeline Review, H1 2015 - Product Thumbnail Image

Renal Cell Carcinoma - Pipeline Review, H1 2015

  • Report
  • 609 Pages
From
TCR & CAR Engineered T-Cell and NK Cell Therapeutics 2016 - Product Thumbnail Image

TCR & CAR Engineered T-Cell and NK Cell Therapeutics 2016

  • Report
  • 388 Pages
From
Regenerative Medicine - Global Trends, Estimates and Forecasts, 2013-2019 - Product Thumbnail Image

Regenerative Medicine - Global Trends, Estimates and Forecasts, 2013-2019

  • Report
  • 379 Pages
From
Monoclonal Antibody Based Products - Global Strategic Business Report - Product Thumbnail Image

Monoclonal Antibody Based Products - Global Strategic Business Report

  • Report
  • 527 Pages
From
Myelodysplastic Syndrome - Pipeline Review, H1 2018 - Product Thumbnail Image

Myelodysplastic Syndrome - Pipeline Review, H1 2018

  • Report
  • 1006 Pages
From
Dermatology Therapeutics Drug Development Pipeline Review, 2016 - Product Thumbnail Image

Dermatology Therapeutics Drug Development Pipeline Review, 2016

  • Report
  • 432 Pages
From
T-cell Immunotherapy: Clinical Trial Tracker - Product Thumbnail Image

T-cell Immunotherapy: Clinical Trial Tracker

  • Clinical Trials
From
Malignant Glioma - Pipeline Insight, 2018 - Product Thumbnail Image

Malignant Glioma - Pipeline Insight, 2018

  • Drug Pipelines
  • 50 Pages
From
Pancreatic Cancer Drugs - Global Strategic Business Report - Product Thumbnail Image

Pancreatic Cancer Drugs - Global Strategic Business Report

  • Report
  • 405 Pages
From
Loading Indicator
adroll